Facts Matter (Feb. 16): Exclusive: Pfizer Clinical Trial Whistleblower Presses Forward With Lawsuit Without US Government’s Help

According to its newly published earnings report, Pfizer is pretty much swimming in cash. In fact, just from the vaccine alone, it has brought in $36 billion—making its vaccine the No. 1 top-selling pharmaceutical product ever in a single year from any company, by a very wide margin. However, not everything is going smoothly fo...